1. Mandatory role of endoplasmic reticulum and its pentose phosphate shunt in the myocardial defense mechanisms against the redox stress induced by anthracyclines.
- Author
-
Sambuceti G, Cossu V, Vitale F, Bianconi E, Carta S, Venturi C, Chiesa S, Lanfranchi F, Emionite L, Carlone S, Sofia L, D'Amico F, Di Raimondo T, Chiola S, Orengo AM, Morbelli S, Ameri P, Bauckneht M, and Marini C
- Subjects
- Animals, Mice, Anthracyclines adverse effects, Oxidative Stress drug effects, Doxorubicin adverse effects, Doxorubicin pharmacology, Myocytes, Cardiac metabolism, Myocytes, Cardiac drug effects, Myocytes, Cardiac pathology, Ryanodine Receptor Calcium Release Channel metabolism, Ryanodine Receptor Calcium Release Channel genetics, Myocardium metabolism, Myocardium pathology, Sarcoplasmic Reticulum Calcium-Transporting ATPases metabolism, Sarcoplasmic Reticulum Calcium-Transporting ATPases genetics, Glucosephosphate Dehydrogenase metabolism, Glucosephosphate Dehydrogenase genetics, Male, Carbohydrate Dehydrogenases, Pentose Phosphate Pathway drug effects, Oxidation-Reduction drug effects, Mice, Knockout, Endoplasmic Reticulum metabolism, Endoplasmic Reticulum drug effects
- Abstract
Anthracyclines' cardiotoxicity involves an accelerated generation of reactive oxygen species. This oxidative damage has been found to accelerate the expression of hexose-6P-dehydrogenase (H6PD), that channels glucose-6-phosphate (G6P) through the pentose phosphate pathway (PPP) confined within the endoplasmic/sarcoplasmic reticulum (SR). To verify the role of SR-PPP in the defense mechanisms activated by doxorubicin (DXR) in cardiomyocytes, we tested the effect of this drug in H6PD knockout mice (H6PD
-/- ). Twenty-eight wildtype (WT) and 32 H6PD-/- mice were divided into four groups to be treated with intraperitoneal administration of saline (untreated) or DXR (8 mg/Kg once a week for 3 weeks). One week thereafter, survivors underwent imaging of18 F-deoxyglucose (FDG) uptake and were sacrificed to evaluate the levels of H6PD, glucose-6P-dehydrogenase (G6PD), G6P transporter (G6PT), and malondialdehyde. The mRNA levels of SR Ca2+ -ATPase 2 (Serca2) and ryanodine receptors 2 (RyR2) were evaluated and complemented with Hematoxylin/Eosin staining and transmission electron microscopy. During the treatment period, 1/14 DXR-WT and 12/18 DXR-H6PD-/- died. At microPET, DXR-H6PD-/- survivors displayed an increase in left ventricular size (p < 0.001) coupled with a decreased urinary output, suggesting a severe hemodynamic impairment. At ex vivo analysis, H6PD-/- condition was associated with an oxidative damage independent of treatment type. DXR increased H6PD expression only in WT mice, while G6PT abundance increased in both groups, mismatching a generalized decrease of G6PD levels. Switching-off SR-PPP impaired reticular accumulation of Ca2+ decelerating Serca2 expression and upregulating RyR2 mRNA level. It thus altered mitochondrial ultrastructure eventually resulting in a cardiomyocyte loss. The recognized vulnerability of SR to the anthracycline oxidative damage is counterbalanced by an acceleration of G6P flux through a PPP confined within the reticular lumen. The interplay of SR-PPP with the intracellular Ca2+ exchanges regulators in cardiomyocytes configure the reticular PPP as a potential new target for strategies aimed to decrease anthracycline toxicity., (© 2023. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF